KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Guardant Health (GH) Return on Sales (2017 - 2025)

Guardant Health (GH) has disclosed Return on Sales for 9 consecutive years, with 0.46% as the latest value for Q4 2025.

  • Quarterly Return on Sales rose 9.0% to 0.46% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.42% through Dec 2025, up 17.0% year-over-year, with the annual reading at 0.42% for FY2025, 17.0% up from the prior year.
  • Return on Sales hit 0.46% in Q4 2025 for Guardant Health, down from 0.35% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.35% in Q3 2025 to a low of 2.1% in Q2 2022.
  • Historically, Return on Sales has averaged 0.88% across 5 years, with a median of 0.68% in 2021.
  • Biggest five-year swings in Return on Sales: plummeted -104bps in 2022 and later skyrocketed 157bps in 2023.
  • Year by year, Return on Sales stood at 0.67% in 2021, then crashed by -65bps to 1.1% in 2022, then decreased by -9bps to 1.21% in 2023, then soared by 54bps to 0.55% in 2024, then rose by 17bps to 0.46% in 2025.
  • Business Quant data shows Return on Sales for GH at 0.46% in Q4 2025, 0.35% in Q3 2025, and 0.43% in Q2 2025.